My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
April 2014
Policy and Advocacy
HIVMA, IDSA Members Named to Work Group as HOPE Implementation Begins
As follow up to the recent passage of the HIV Organ Policy Equity Act (HOPE), the Organ Procurement and Transplantation Network (OPTN) has named 15 clinicians and professionals involved in organ donation and transplantation to a work group to consider policy revisions to allow recovery of organs from HIV-positive deceased donors for use by HIV-infected patients in need of organ transplants.

The HOPE Act, supported by the HIV Medicine Association (HIVMA), calls for the U.S. Department of Health and Human Services (DHHS) to develop and publish criteria for the conduct of research relating to the transplantation of organs from donors known to be HIV-positive to recipients who are HIV-positive. Together, DHHS and OPTN will review the results of the scientific research and assess the feasibility, effectiveness, and safety of using organs from HIV-positive donors. A key aspect in policy consideration is ensuring that HIV status would be properly identified at all stages of donation and transplantation.

Several HIVMA and IDSA members were among the 15 named to the OPTN work group including:

  • Michael Green, MD, MPH, FIDSA, professor of pediatrics and surgery at the University of Pittsburgh School of Medicine
  • Daniel Kaul, MD, FIDSA, director of the transplant infectious diseases service at the University of Michigan Medical Center
  • Costi Sifri, MD, FIDSA, associate professor of medicine at the University of Virginia School of Medicine, and
  • Cameron Wolfe, MD, attending faculty in transplant infectious disease at Duke University Medical Center.



< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Clinical Practice Management
Pocketcards Now Available for HIV and Vaccination Guidelines
IDSA Takes Leadership Role in Developing Quality Measures for ID
Policy and Advocacy
IDSA Weighs in on Fiscal Year 2015 Appropriations Process
IDSA Joins SHEA in Commenting on Respiratory Protective Devices
HIVMA, IDSA Members Named to Work Group as HOPE Implementation Begins
Patient Care and Science
NIAID/NIH Announce Antibiotic Research Funding Opportunity
New Guidance Highlights How to Reduce Catheter - Associated UTIs
EIN Update: EIN Links Clinicians and Researchers
Science Speaks
The Center for Global Health Policy’s blog, Science Speaks, covered new Hep C guidelines from WHO, the new U.S. Global AIDS Coordinator, promising news in antiretroviral access, and more
Education and Resources
OFID Names New Associate Editors
Share Your Feedback on IDSA’s Journals
You and Your Colleagues
26 Medical Students Set to Explore ID Firsthand
Members on the Move
New Members
Top Stories
From the President: What’s Keeping Young People From Choosing ID?
Journal Club
Patient Access to Medicare Act: Disappointment for SGR Fix, Win for Diagnostics
Progress Continues on Antimicrobial Resistance as New Drugs Loom on Horizon
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.